sellWeak cluster of 710b5-1 plan
Douglas Evan Godshall sold $2.3M of SWAV
President & CEO at Shockwave Medical, Inc.. 10,000 shares at an average of $231.56, traded Feb 15, 2024, filed Feb 16, 2024.
Warning score
30Value
$2.3M
10,000 shares
Holdings after
162,762
-6% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- +25Trade size$2.3M at market
- 0Share of holdings soldSold 5.8% of holdings
- +15Cluster7 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001642545-24-000044, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 15, 2024 | MOption exercise Common Stock10b5-1 | +10,000 | $3.42 | $34k | 172,762 | Feb 16, 2024 |
| Feb 15, 2024 | SOpen-market sale Common Stock10b5-1 | -560 | $228.28 | $128k | 172,202 | Feb 16, 2024 |
| Feb 15, 2024 | SOpen-market sale Common Stock10b5-1 | -2,230 | $229.82 | $512k | 169,972 | Feb 16, 2024 |
| Feb 15, 2024 | SOpen-market sale Common Stock10b5-1 | -2,800 | $230.86 | $646k | 167,172 | Feb 16, 2024 |
| Feb 15, 2024 | SOpen-market sale Common Stock10b5-1 | -1,987 | $231.74 | $460k | 165,185 | Feb 16, 2024 |
| Feb 15, 2024 | SOpen-market sale Common Stock10b5-1 | -792 | $232.74 | $184k | 164,393 | Feb 16, 2024 |
| Feb 15, 2024 | SOpen-market sale Common Stock10b5-1 | -200 | $233.54 | $47k | 164,193 | Feb 16, 2024 |
| Feb 15, 2024 | SOpen-market sale Common Stock10b5-1 | -600 | $235.21 | $141k | 163,593 | Feb 16, 2024 |
| Feb 15, 2024 | SOpen-market sale Common Stock10b5-1 | -831 | $236.13 | $196k | 162,762 | Feb 16, 2024 |
| Feb 15, 2024 | MOption exercise Stock Optionderivative10b5-1 | -10,000 | $0.00 | $0 | 294,799 | Feb 16, 2024 |
Related signals
Other insiders at Shockwave Medical, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | Shockwave Medical, Inc. | Laura Francis director | $450k 1,500 shares | -30% | |
| 33Weak | Shockwave Medical, Inc. | Isaac Zacharias President, CCO | $1.2M 4,000 shares | -7% | |
| 23Weak | Shockwave Medical, Inc. | Frank T Watkins director | $507k 2,000 shares | -31% | |
| 10Weak | Shockwave Medical, Inc. | Trinh Phung VP, Finance | $5,316 21 shares | -0% | |
| 40Moderate | Shockwave Medical, Inc. | Isaac Zacharias President, CCO | $1.0M 4,000 shares | -6% | |
| 60Notable | Shockwave Medical, Inc. | Frederic H Moll director | $15M 60,000 shares | -17% | |
| 21Weak | Shockwave Medical, Inc. | Trinh Phung VP, Finance | $155k 599 shares | -2% | |
| 13Weak | Shockwave Medical, Inc. | Laura Francis director | $250k 1,000 shares | -22% | |
| 24Weak | Shockwave Medical, Inc. | Trinh Phung VP, Finance | $299k 1,287 shares | -4% | |
| 22Weak | Shockwave Medical, Inc. | Frank T Watkins director | $464k 2,000 shares | -31% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.